Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
2019
Criterium:	Position:
Overall Score:	> 1000
Total Number of Projects:	600-700
2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	600-700
Networking Rank (Reputation):	> 1000
2016
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2023-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 29
As coordinator: 1
As participant: 28
Sole participant: 0
Coordinator / Participant Ratio: 0.04^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2022	0	1.880.262	0		1
2021	0	26.334.266	617.013		5
2020	0	48.187.587	243.750		2
2019	0	100.828.086	0		7
2018	0	38.022.361	505.577		6
2017	3.556.208	23.549.833	1.471.729	1	2
2016	0	21.066.307	750.570		5

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
JANSSEN PHARMACEUTICA NV	12
NOVARTIS PHARMA	10
PFIZER LIMITED	10
BAYER	8
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	8
KATHOLIEKE UNIVERSITEIT LEUVEN	8
SANOFIAVENTIS	7
ABBVIE INC	6
F HOFFMANNLA ROCHE	6
ASTRAZENECA	5
ELI LILLY AND COMPANY LIMITED	5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	5
NOVO NORDISK	5
TAKEDA PHARMACEUTICALS INTERNATIONAL	5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	5
UCB BIOPHARMA	5
UNIVERSITY OF DUNDEE	5
ASTELLAS PHARMA EUROPE BV	4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	4
INSTITUT DE RECHERCHES SERVIER	4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	4
LEIDS UNIVERSITAIR MEDISCH CENTRUM	4
MERCK SHARP & DOHME CORP	4
TAKEDA DEVELOPMENT CENTRE EUROPE	4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	4
AMGEN LIMITED	3
ASTRAZENECA AB	3
BAYER AKTIENGESELLSCHAFT	3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS	3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	3
COVANCE LABORATORIES	3
GRUNENTHAL	3
STICHTING LYGATURE	3
UNIVERSITEIT UTRECHT	3
UNIVERSITY OF BIRMINGHAM	3
UNIVERSITY OF DURHAM	3
UNIVERSITY OF NEWCASTLE UPON TYNE	3
UNIVERSITY OF OSLO	3
BAYERISCHE FORSCHUNGSALLIANZ GEMEINNUTZIGE	2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH	2
EINDHOVEN UNIVERSITY OF TECHNOLOGY	2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	2
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON	2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS	2
EUROPEAN CANCER PATIENT COALITION	2
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE	2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL	2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES	2
FLUXIM	2
FORUM DES PATIENTS EUROPEENS	2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG	2
FUNDACIO INSTITUT DE RECERCA BIOMEDICA	2
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA	2
H LUNDBECK AS	2
IKTOS	2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER	2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS	2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT	2
KING'S COLLEGE LONDON	2
LUND UNIVERSITY	2
MEDIZINISCHE UNIVERSITAT INNSBRUCK	2
NATIONAL UNIVERSITY CORPORATION KYOTO UNIVERSITY	2
NATIONAL UNIVERSITY CORPORATION KYUSHU UNIVERSITY	2
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU	2
OWKIN FRANCE	2
PFABRUSSELS	2
SANOFIAVENTIS DEUTSCHLAND	2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT	2
SERVICIO MADRILENO DE SALUD	2
SIMBEYOND BV	2
STATENS LEGEMIDDELVERK	2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS	2
STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY	2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	2
SYNCOM BV	2
TECHNISCHE UNIVERSITAET DARMSTADT	2
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY	2
THE EUROPEAN MEDICINES AGENCY	2
THE SYNERGIST	2
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS	2
THE UNIVERSITY OF LIVERPOOL	2
THE UNIVERSITY OF MANCHESTER	2
TRANSGENE	2
UNIVERSITAET ZUERICH	2
UNIVERSITAT BAYREUTH	2
UNIVERSITATSKLINIKUM ERLANGEN	2
UNIVERSITE DE BORDEAUX	2
UNIVERSITE DE GENEVE	2
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK	2
UNIVERSITY OF BOLOGNA	2
UNIVERSITY OF LEEDS	2
UPPSALA UNIVERSITET	2
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV	2
3D LIFEPRINTS UK	1
ABBVIE	1
ACADEMISCH ZIEKENHUIS GRONINGEN	1
ACCELOPMENT	1

Constancy:

Total number of partners: 657
Partner loyalty:
Frequent Partner: (> 2 projects): 190
Rare Partner: 467
Frequent / Rare Partner Ratio: 0.41

Project overview:

Start date	Project	acronym	role	funding	partners
2022-10-01	- addressing the challenges of high-performance solution-processed OLEDs using sustainable materials	TADFsolutions	participant	1.880.262	18
2021-09-01	BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe	BEAMER	participant	5.948.903	31
2021-07-01	Real World Handling of Protein Drugs - Exploration, Evaluation and Education	RealHOPE	participant	3.139.984	27
2021-07-01	Building a reproducible single-cell experimental workflow to capture tumour drug persistence	PERSIST-SEQ	participant	7.057.980	16
2021-05-01	Innovative high-value cosmetic products from plants and plant cells	InnCoCells	participant	7.905.559	18
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2020-10-01	HIGH PERFORMING AND SAFE SOLVENT DERIVED FROM CELLULOSIC FEEDSTOCKS	ReSolute	participant	11.628.401	16
2020-04-01	Corona Accelerated R&D in Europe	CARE	participant	36.559.186	43
2019-12-01	Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies	imSAVAR	participant	10.999.316	28
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	33
2019-06-01	MachinE Learning Ledger Orchestration for Drug DiscoverY	MELLODDY	participant	8.000.000	17
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	35
2019-04-01	Appearance Printing - European Advanced Research School	ApPEARS	participant	4.265.884	15
2019-04-01	Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation	ConcePTION	participant	15.299.991	53
2019-03-01	Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts	IMMUcan	participant	17.830.000	28
2018-12-01	European Screening Centre; Unique Library for Attractive Biology	ESCulab	participant	18.249.993	20
2018-11-01	Chemical Engineering Immersive Learning	CHARMING	participant	4.060.228	13
2018-10-01	Using the smart matrix approach to enhance TADF-OLED efficiency and lifetime	TADFlife	participant	3.942.037	21
2018-03-01	Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.	PARADIGM	participant	4.498.931	35
2018-01-01	Computational ONcology TRaining Alliance	CONTRA	participant	3.863.978	15
2018-01-01	European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets	UbiCODE	participant	3.407.194	20
2017-09-01	Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management	eTRANSAFE	participant	20.000.000	27
2017-02-01	Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055	DO-IT	participant	3.549.833	36
2017-01-01	Development of high-performance, hyperfluorescence OLEDs for use in display applications and solid state lighting	HyperOLED	coordinator	3.556.208	5
2016-10-01	Continuous Resolution and Deracemization of Chiral Compounds by Crystallization	CORE	participant	3.920.690	15
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33
2016-09-01	Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network	SYNTRAIN	participant	3.990.269	13
2016-05-01	Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines	PEARRL	participant	3.856.253	10
2016-02-01	Production technology to achieve low Cost and Highly Efficient phOtovoltaic Perovskite Solar cells	CHEOPS	participant	3.299.095	12

MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN - Germany